Kuros Biosciences AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	935	710	120	48	51	55
Market Cap Growth	30.97%	493.74%	148.06%	-5.72%	-6.74%	27.87%
Enterprise Value	919	699	107	31	31	44
Last Close Price	24.05	18.92	3.25	1.35	1.62	1.71
PS Ratio	9.86	10.66	3.82	2.99	4.57	16.40
PB Ratio	13.29	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	29.24	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	-	393.96	-	-	-	-
P/OCF Ratio	1242.18	256.57	-	-	-	-
EV/Sales Ratio	9.32	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	148.40	385.86	-	-	-	-
EV/EBIT Ratio	249.74	7414.24	-	-	-	-
EV/FCF Ratio	-1485.56	387.93	-	-	-	-
Debt / Equity Ratio	0.02	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.28	0.66	-	-	-	-
Debt / FCF Ratio	-	0.88	-	-	-	-
Net Debt / Equity Ratio	-0.22	-0.28	-0.21	-0.32	-0.34	-0.31
Net Debt / EBITDA Ratio	-2.86	-7.89	4.04	2.95	4.17	2.74
Net Debt / FCF Ratio	24.71	-7.93	1.32	2.86	4.58	2.79
Asset Turnover	1.10	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.14	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.68	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.25	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-8.62%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	2.57%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital Employed (ROCE)	4.60%	0.20%	-8.20%	-14.00%	-11.00%	-13.00%
Earnings Yield	-0.60%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	-0.07%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-36.07%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.